Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Donald Trump blamed for job losses as Indian IT workers face cuts May 24, 2017 India to add more petrochemical capacity: Dharmendra Pradhan July 29, 2017 Ministers’ panel starts hearing case for bailing out debt-laden telecom firms June 12, 2017